Pidotimod vs Thymogen
Head-to-head comparison of Pidotimod (3-L-Pyroglutamyl-L-Thiazolidine-4-Carboxylic Acid) and Thymogen (L-Glutamyl-L-Tryptophan) — benefits, dosing, side effects, research data, and where to buy.
| Property | Pidotimod | Thymogen |
|---|---|---|
| Category | Immune Support | Immune Support |
| Full Name | 3-L-Pyroglutamyl-L-Thiazolidine-4-Carboxylic Acid | L-Glutamyl-L-Tryptophan |
| Molecular Weight | 244.27 Da | 345.34 Da |
| Half-Life | 3-4 h | 1-2 h |
| Amino Acids | 2 | 2 |
| Typical Dose | 400-800 mg/day | 100-300 mcg |
| Route | Oral | Intranasal |
| Purity | ≥98% | ≥98% |
| Studies Count | 200 | 60 |
| Research Status | Clinical | Clinical |
Pidotimod Benefits
- ✓oral-immune-support
- ✓respiratory-infection-adjunct
- ✓innate-immunity
- ✓adaptive-immunity-support
Thymogen Benefits
- ✓cellular-immune-support
- ✓t-cell-signaling
- ✓recovery-adjunct
- ✓infection-resilience
Pidotimod Dosing
400 mg PO BID|typically 15-30 days|repeated seasonal cycles in studies
Thymogen Dosing
100-300 mcg/day|intranasal or IM|5-10 day cycles
Pidotimod Side Effects
- ⚠nausea
- ⚠diarrhea
- ⚠rash
Thymogen Side Effects
- ⚠nasal irritation
- ⚠headache
- ⚠hypersensitivity
Research Overview
Pidotimod
Pidotimod has human data in recurrent infections, especially where immune stimulation or reduced infection frequency is the target. Published work commonly reports improvements in phagocyte function, mucosal defense, and fewer respiratory infection episodes.
Thymogen
Thymogen has been studied as a short thymic peptide-like dipeptide with immunoregulatory activity. The literature focuses on lymphocyte function, cytokine modulation, and use in recurrent respiratory infections or immune suppression states.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.